SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16764336
Source:
http://linkedlifedata.com/resource/pubmed/id/16764336
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0457454
,
umls-concept:C0475463
,
umls-concept:C0546816
,
umls-concept:C0751967
,
umls-concept:C1444662
pubmed:issue
3
pubmed:dateCreated
2006-6-12
pubmed:abstractText
The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16764336-16764335
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9509185
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1352-4585
pubmed:author
pubmed-author:BendtzenKlausK
,
pubmed-author:Danish Multiple Sclerosis Group
,
pubmed-author:Koch-HenriksenNilsN
,
pubmed-author:PetersenBodilB
,
pubmed-author:RavnborgMadsM
,
pubmed-author:RossChristianC
,
pubmed-author:SorensenPer SoelbergPS
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
247-52
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16764336-Adjuvants, Immunologic
,
pubmed-meshheading:16764336-Antibodies
,
pubmed-meshheading:16764336-Female
,
pubmed-meshheading:16764336-Follow-Up Studies
,
pubmed-meshheading:16764336-Humans
,
pubmed-meshheading:16764336-Interferon-beta
,
pubmed-meshheading:16764336-Male
,
pubmed-meshheading:16764336-Multiple Sclerosis, Relapsing-Remitting
,
pubmed-meshheading:16764336-Neutralization Tests
,
pubmed-meshheading:16764336-Retrospective Studies
,
pubmed-meshheading:16764336-Time Factors
pubmed:year
2006
pubmed:articleTitle
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis.
pubmed:affiliation
Danish Multiple Sclerosis Research Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't